Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI033119-04
Application #
2068113
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1991-12-01
Project End
1997-06-30
Budget Start
1994-12-01
Budget End
1997-06-30
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Pathology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Reid, S D; Hoe, N P; Smoot, L M et al. (2001) Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. J Clin Invest 107:393-9
Lukomski, S; Nakashima, K; Abdi, I et al. (2001) Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation. Infect Immun 69:1729-38
Kagawa, T F; Cooney, J C; Baker, H M et al. (2000) Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc Natl Acad Sci U S A 97:2235-40
Lukomski, S; Nakashima, K; Abdi, I et al. (2000) Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect Immun 68:6542-53
Mascini, E M; Jansze, M; Schellekens, J F et al. (2000) Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 181:631-8
Gubba, S; Cipriano, V; Musser, J M (2000) Replacement of histidine 340 with alanine inactivates the group A Streptococcus extracellular cysteine protease virulence factor. Infect Immun 68:3716-9
Hoe, N P; Kordari, P; Cole, R et al. (2000) Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis 182:1425-36
Lukomski, S; Hoe, N P; Abdi, I et al. (2000) Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68:535-42
Stockbauer, K E; Magoun, L; Liu, M et al. (1999) A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc Natl Acad Sci U S A 96:242-7
Matsuka, Y V; Pillai, S; Gubba, S et al. (1999) Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity. Infect Immun 67:4326-33

Showing the most recent 10 out of 44 publications